Coverage of primary and booster vaccination against COVID-19 by socioeconomic level: A nationwide cross-sectional registry study

被引:10
作者
Hansen, Bo T. [1 ,2 ,5 ]
Labberton, Angela S. [3 ]
Kour, Prabhjot [4 ]
Kraft, Kristian B. [3 ]
机构
[1] Norwegian Inst Publ Hlth, Dept Infect Control & Vaccine, Oslo, Norway
[2] Canc Registry Norway, Dept Res, Oslo, Norway
[3] Norwegian Inst Publ Hlth, Div Hlth Serv, Oslo, Norway
[4] Norwegian Inst Publ Hlth, Dept Infect Control & Preparedness, Oslo, Norway
[5] Norwegian Inst Publ Hlth, Dept Infect Control & Vaccine, Postboks 222 Skoyen, N-0213 Oslo, Norway
关键词
Booster vaccine; vaccine hesitancy; social inequity; sociodemographic correlates; socioeconomic correlates; COVID-19; vaccination program; vaccine coverage; vaccine uptake; disparity; HOSPITALIZATIONS; INFECTIONS; VACCINES; BNT162B2;
D O I
10.1080/21645515.2023.2188857
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
High and equitable COVID-19 vaccination coverage is important for pandemic control and prevention of health inequity. However, little is known about socioeconomic correlates of booster vaccination coverage. In this cross-sectional study of all Norwegian adults in the national vaccination program (N = 4,190,655), we use individual-level registry data to examine coverage by levels of household income and education of primary (>= 2 doses) and booster (>= 3 doses) vaccination against COVID-19. We stratify the analyses by age groups with different booster recommendations and report relative risk ratios (RR) for vaccination by 25 August 2022. In the 18-44 y group, individuals with highest vs. lowest education had 94% vs. 79% primary coverage (adjusted RR (adjRR) 1.15, 95%CI 1.14-1.15) and 67% vs. 38% booster coverage (adjRR 1.55, 95% CI 1.55-1.56), while individuals with highest vs. lowest income had 94% vs. 81% primary coverage (adjRR 1.10, 95%CI 1.10-1.10) and 60% vs. 43% booster coverage (adjRR 1.23, 95%CI 1.22-1.24). In the >= 45 y group, individuals with highest vs. lowest education had 96% vs. 92% primary coverage (adjRR 1.02, 95%CI 1.02-1.02) and 88% vs. 80% booster coverage (adjRR 1.09, 95%CI 1.09-1.09), while individuals with highest vs. lowest income had 98% vs. 82% primary coverage (adjRR 1.16, 95%CI 1.16-1.16) and 92% vs. 64% booster coverage (adjRR 1.33, 95%CI 1.33-1.34). In conclusion, we document large socioeconomic inequalities in COVID-19 vaccination coverage, especially for booster vaccination, even though all vaccination was free-of-charge. The results highlight the need to tailor information and to target underserved groups for booster vaccination.
引用
收藏
页数:10
相关论文
共 34 条
  • [1] Geographic, Occupational, and Sociodemographic Variations in Uptake of COVID-19 Booster Doses Among Fully Vaccinated US Adults, December 1, 2021, to January 10, 2022
    Agaku, Israel T.
    Adeoye, Caleb
    Long, Theodore G.
    [J]. JAMA NETWORK OPEN, 2022, 5 (08) : E2227680
  • [2] Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England
    Andrews, Nick
    Stowe, Julia
    Kirsebom, Freja
    Toffa, Samuel
    Sachdeva, Ruchira
    Gower, Charlotte
    Ramsay, Mary
    Bernal, Jamie Lopez
    [J]. NATURE MEDICINE, 2022, 28 (04) : 831 - +
  • [3] [Anonymous], 2013, Health 2020, A European policy framework and strategy for the 21st century
  • [4] [Anonymous], EUROSTAT
  • [5] BNT162b2 Vaccine Booster and Mortality Due to Covid-19
    Arbel, Ronen
    Hammerman, Ariel
    Sergienko, Ruslan
    Friger, Michael
    Peretz, Alon
    Netzer, Doron
    Yaron, Shlomit
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (26) : 2413 - 2420
  • [6] Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
    Bernal, Jamie Lopez
    Andrews, Nick
    Gower, Charlotte
    Robertson, Chris
    Stowe, Julia
    Tessier, Elise
    Simmons, Ruth
    Cottrell, Simon
    Roberts, Richard
    O'Doherty, Mark
    Brown, Kevin
    Cameron, Claire
    Stockton, Diane
    McMenamin, Jim
    Ramsay, Mary
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 373
  • [7] Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination
    Betsch, Cornelia
    Schmid, Philipp
    Heinemeier, Dorothee
    Korn, Lars
    Holtmann, Cindy
    Boehm, Robert
    [J]. PLOS ONE, 2018, 13 (12):
  • [8] Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study
    de Lusignan, Simon
    Dorward, Jienchi
    Correa, Ana
    Jones, Nicholas
    Akinyemi, Oluwafunmi
    Amirthalingam, Gayatri
    Andrews, Nick
    Byford, Rachel
    Dabrera, Gavin
    Elliot, Alex
    Ellis, Joanna
    Ferreira, Filipa
    Bernal, Jamie Lopez
    Okusi, Cecilia
    Ramsay, Mary
    Sherlock, Julian
    Smith, Gillian
    Williams, John
    Howsam, Gary
    Zambon, Maria
    Joy, Mark
    Hobbs, F. D. Richard
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (09) : 1034 - 1042
  • [9] Monitoring sociodemographic inequality in COVID-19 vaccination uptake in England: a national linked data study
    Dolby, Ted
    Finning, Katie
    Baker, Allan
    Fowler-Dowd, Leigh
    Khunti, Kamlesh
    Razieh, Cameron
    Yates, Thomas
    Nafilyan, Vahe
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2022, 76 (07) : 646 - 652
  • [10] A population-based cohort study of socio-demographic risk factors for COVID-19 deaths in Sweden
    Drefahl, Sven
    Wallace, Matthew
    Mussino, Eleonora
    Aradhya, Siddartha
    Kolk, Martin
    Branden, Maria
    Malmberg, Bo
    Andersson, Gunnar
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)